{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:15:06Z","timestamp":1767705306362,"version":"build-2065373602"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32GM113846 -10","NS062158"],"award-info":[{"award-number":["5T32GM113846 -10","NS062158"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ymgme.2023.107539","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T06:34:33Z","timestamp":1676010873000},"page":"107539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type II"],"prefix":"10.1016","volume":"138","author":[{"given":"Miles C.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lalitha R.","family":"Belur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea D.","family":"Karlen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Podetz-Pedersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Erlanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanut","family":"Laoharawee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Furcich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troy C.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davis","family":"Seelig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beau R.","family":"Webber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Scott","family":"McIvor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2023.107539_bb0005","series-title":"Online Metab. Mol. Bases Inherit. Dis","article-title":"The Mucopolysaccharidoses","author":"Neufeld","year":"2019"},{"key":"10.1016\/j.ymgme.2023.107539_bb0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2023.107539_bb0015","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.3390\/ijms22157888","article-title":"Differences in MPS I and MPS II disease manifestations","volume":"22","author":"Hampe","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2023.107539_bb0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2023.107539_bb0025","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (hunter syndrome): a preliminary report","volume":"91","author":"Muenzer","year":"2002","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.ymgme.2023.107539_bb0030","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/hmg\/ddl038","article-title":"Correction of hunter syndrome in the MPSII mouse model by AAV2\/8-mediated gene delivery","volume":"15","author":"Cardone","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2023.107539_bb0035","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86696","article-title":"CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (hunter syndrome)","volume":"1","author":"Motas","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymgme.2023.107539_bb0040","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s10545-007-0641-8","article-title":"The characterization of a murine model of mucopolysaccharidosis II (hunter syndrome)","volume":"30","author":"Garcia","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107539_bb0045","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1038\/mtm.2014.68","article-title":"A novel, long-lived, and highly engraftable immunodeficient mouse model of mucopolysaccharidosis type I","volume":"2","author":"Mendez","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgme.2023.107539_bb0050","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R\u03b3null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J. Immunol."},{"year":"2014","series-title":"Manipulating the Mouse Embryo: A Laboratory Manual","author":"Behringer","key":"10.1016\/j.ymgme.2023.107539_bb0055"},{"key":"10.1016\/j.ymgme.2023.107539_bb0060","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ymthe.2018.03.002","article-title":"Dose-dependent prevention of metabolic and neurologic disease in murine MPS II by ZFN-mediated in vivo genome editing","volume":"26","author":"Laoharawee","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0065","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1023\/A:1012763026526","article-title":"A fluorimetric enzyme assay for the diagnosis of MPS II (hunter disease)","volume":"24","author":"Voznyi","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2023.107539_bb0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/h0077579","article-title":"Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat","volume":"93","author":"Barnes","year":"1979","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.ymgme.2023.107539_bb0075","series-title":"Pre-Clin. Models Tech. Protoc","first-page":"105","article-title":"The Y-maze for assessment of spatial working and reference memory in mice","author":"Kraeuter","year":"2019"},{"key":"10.1016\/j.ymgme.2023.107539_bb0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","article-title":"The mechanism of double-strand DNA break repair by the nonhomologous DNA end joining pathway","volume":"79","author":"Lieber","year":"2010","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ymgme.2023.107539_bb0085","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1038\/ncomms15464","article-title":"CRISPR\/Cas9 targeting events cause complex deletions and insertions at 17 sites in the mouse genome","volume":"8","author":"Shin","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2023.107539_bb0090","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","article-title":"Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements","volume":"36","author":"Kosicki","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymgme.2023.107539_bb0095","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/clinchem\/43.8.1325","article-title":"Diagnosis of lysosomal storage disorders: evaluation of lysosome-associated membrane protein LAMP-1 as a diagnostic marker","volume":"43","author":"Meikle","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2023.107539_bb0100","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.ymthe.2021.01.027","article-title":"Clearance of heparan sulfate in the brain prevents neurodegeneration and neurocognitive impairment in MPS II mice","volume":"29","author":"Morimoto","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0105","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708730","article-title":"Brain-targeted stem cell gene therapy corrects mucopolysaccharidosis type II via multiple mechanisms","volume":"10","author":"Gleitz","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgme.2023.107539_bb0110","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.omtm.2020.09.012","article-title":"Ex vivo gene therapy treats bone complications of mucopolysaccharidosis type II mouse models through bone remodeling reactivation","volume":"19","author":"Wada","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.ymgme.2023.107539_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172435","article-title":"Identification of age-dependent motor and neuropsychological behavioural abnormalities in a mouse model of mucopolysaccharidosis type II","volume":"12","author":"Gleitz","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2023.107539_bb0120","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ymgme.2021.03.002","article-title":"The natural history of neurocognition in MPS disorders: a review","volume":"133","author":"Shapiro","year":"2021","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107539_bb0125","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1089\/hum.2016.184","article-title":"Prevention of neurocognitive deficiency in mucopolysaccharidosis type II mice by central nervous system\u2013directed, AAV9-mediated iduronate sulfatase gene transfer","volume":"28","author":"Laoharawee","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/hum.2022.162","article-title":"Neurologic recovery in MPS I and MPS II mice by AAV9-mediated gene transfer to the CNS after the development of cognitive dysfunction","volume":"34","author":"Podetz-Pedersen","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0135","article-title":"Non-invasive intravenous administration of AAV9 transducing iduronate sulfatase leads to global metabolic correction and prevention of neurologic deficits in a mouse model of hunter syndrome","volume":"34","author":"Laoharawee","year":"2023","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2023.107539_bb0140","doi-asserted-by":"crossref","first-page":"e1258","DOI":"10.1542\/peds.2010-1274","article-title":"Natural progression of neurological disease in mucopolysaccharidosis type II","volume":"127","author":"Holt","year":"2011","journal-title":"Pediatrics."},{"key":"10.1016\/j.ymgme.2023.107539_bb0145","first-page":"1","article-title":"A novel preclinical model of mucopolysaccharidosis type II for developing human hematopoietic stem cell gene therapy","author":"Shimada","year":"2022","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0150","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/hum.1996.7.3-283","article-title":"Preclinical studies of lymphocyte gene therapy for mild hunter syndrome (mucopolysaccharidosis type II)","volume":"7","author":"Braun","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/hum.1996.7.4-537","article-title":"Retroviral-mediated transfer of the iduronate-2-sulfatase gene into lymphocytes for treatment of mild hunter syndrome (mucopolysaccharidosis type II). University of Minnesota Medical School, Minneapolis, Minnesota","volume":"7","author":"Whitley","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0160","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/cge.13593","article-title":"Advances in the gene therapy of monogenic blood cell diseases","volume":"97","author":"Bueren","year":"2020","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2023.107539_bb0165","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.3390\/ijms22115490","article-title":"Gene therapy for Mucopolysaccharidosis type II\u2014A review of the current possibilities","volume":"22","author":"Zapolnik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2023.107539_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymthe.2022.10.010","article-title":"First-in-human in vivo genome editing via AAV-zinc finger nucleases for mucopolysaccharidosis I\/II and hemophilia B","author":"Harmatz","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0175","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ymthe.2017.03.025","article-title":"Hematopoietic stem cell gene therapy for storage disease: current and new indications","volume":"25","author":"Biffi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0180","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1089\/hum.2022.141","article-title":"Phenotypic correction of murine mucopolysaccharidosis type II by engraftment of ex vivo lentiviral vector-transduced hematopoietic stem and progenitor cells","volume":"33","author":"Smith","year":"2022","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0185","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/hum.2014.158","article-title":"Hematopoietic stem cell gene therapy corrects neuropathic phenotype in murine model of mucopolysaccharidosis type II","volume":"26","author":"Wakabayashi","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0190","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ymgme.2020.06.007","article-title":"Efficient engraftment of genetically modified cells is necessary to ameliorate central nervous system involvement of murine model of mucopolysaccharidosis type II by hematopoietic stem cell targeted gene therapy","volume":"130","author":"Miwa","year":"2020","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2023.107539_bb0195","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ymthe.2004.03.013","article-title":"Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease","volume":"9","author":"Hofling","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0200","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1182\/blood-2002-08-2597","article-title":"Engraftment of human CD34+ cells leads to widespread distribution of donor-derived cells and correction of tissue pathology in a novel murine xenotransplantation model of lysosomal storage disease","volume":"101","author":"Hofling","year":"2003","journal-title":"Blood."},{"key":"10.1016\/j.ymgme.2023.107539_bb0205","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.stem.2009.05.022","article-title":"Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid Lipofuscinosis","volume":"5","author":"Tamaki","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ymgme.2023.107539_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3205","article-title":"Improvement of motor and behavioral activity in Sandhoff mice transplanted with human CD34+ cells transduced with a HexA\/HexB expressing lentiviral vector","volume":"22","author":"Beegle","year":"2020","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ymgme.2023.107539_bb0215","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1038\/sj.gt.3302314","article-title":"Improved efficacy of gene therapy approaches for Pompe disease using a new, immune-deficient GSD-II mouse model","volume":"11","author":"Xu","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.ymgme.2023.107539_bb0220","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5966\/sctm.2015-0414","article-title":"Generation of human induced pluripotent stem cell-derived bona fide neural stem cells for ex vivo gene therapy of metachromatic leukodystrophy","volume":"6","author":"Meneghini","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ymgme.2023.107539_bb0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/ajt.13520","article-title":"Humanized mouse models for transplant immunology","volume":"16","author":"Kenney","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.ymgme.2023.107539_bb0230","doi-asserted-by":"crossref","first-page":"23579","DOI":"10.1038\/srep23579","article-title":"Transplantation of defined populations of differentiated human neural stem cell progeny","volume":"6","author":"Fortin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymgme.2023.107539_bb0235","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/iid3.124","article-title":"Improved B cell development in humanized NOD-scid IL2R\u03b3null mice transgenically expressing human stem cell factor, granulocyte-macrophage colony-stimulating factor and interleukin-3","volume":"4","author":"Jangalwe","year":"2016","journal-title":"Immun. Inflamm. Dis."},{"key":"10.1016\/j.ymgme.2023.107539_bb0240","doi-asserted-by":"crossref","first-page":"79","DOI":"10.12717\/DR.2019.23.2.079","article-title":"T lymphocyte development and activation in humanized mouse model","volume":"23","author":"Lee","year":"2019","journal-title":"Dev. Reprod."},{"key":"10.1016\/j.ymgme.2023.107539_bb0245","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.stemcr.2015.02.022","article-title":"Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model","volume":"4","author":"Griffin","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.ymgme.2023.107539_bb0250","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114297","article-title":"Autologous, lentivirus-modified, T-rapa cell \u201cmicropharmacies\u201d for lysosomal storage disorders","volume":"14","author":"Nagree","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymgme.2023.107539_bb0255","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1016\/S1525-0016(16)33982-X","article-title":"373. Expression of human Iduronidase from sleeping beauty engineered human B lymphocytes as a cellular therapy for mucopolysaccharidosis type I","volume":"23","author":"Herbig","year":"2015","journal-title":"Mol. Ther."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223001695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719223001695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:53:41Z","timestamp":1761090821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719223001695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1096719223001695"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107539","relation":{},"ISSN":["1096-7192"],"issn-type":[{"type":"print","value":"1096-7192"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type II","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2023.107539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107539"}}